Lantheus is trading at $95.00, down 4.96% in pre-market; no verified report identifies a specific catalyst for the decline.

  • A recent SEC filing disclosed supplemental merger-proxy information after three shareholder complaints and 16 demand letters; it does not establish that the disclosures caused the move.
  • The proposed Curium merger vote is scheduled for October 14, 2026.
  • Major indices are little changed, so broad-market weakness does not clearly explain the drop.